• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

受体高胆红素血症可能减轻缺血再灌注损伤,但未能改善临床肝移植的预后。

Recipient Hyperbilirubinemia May Reduce Ischemia-Reperfusion Injury but Fails to Improve Outcome in Clinical Liver Transplantation.

作者信息

Oltean Mihai, Barrenäs Christian, Martins Paulo Ney, Herlenius Gustaf, Gustafsson Bengt, Friman Styrbjörn, Bennet William

机构信息

The Transplant Institute, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden; Sahlgrenska Academy, The University of Gothenburg, Gothenburg, Sweden.

Sahlgrenska Academy, The University of Gothenburg, Gothenburg, Sweden.

出版信息

Gastroenterol Res Pract. 2016;2016:6964856. doi: 10.1155/2016/6964856. Epub 2016 May 22.

DOI:10.1155/2016/6964856
PMID:27313607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4893452/
Abstract

Background. Exogenous bilirubin may reduce experimental ischemia-reperfusion injury (IRI) due to its antioxidant properties. We studied if early graft exposure to high bilirubin levels in the recipient affects the early IRI and outcomes after liver transplantation (LTx). Methods. In 427 LTx patients, the AUROC curve based on bilirubin and AST at day 1 identified a cutoff of 2.04 mg/dL for the recipient pretransplant bilirubin. Recipients were grouped as having low (group L, n = 152) or high (group H, n = 275) bilirubin. Both groups had similar donor-related variables (age, preservation time, donor BMI > 28, and donor risk index (DRI)). Results. Alanine (ALT) and aspartate (AST) aminotransferase levels were higher in group L at day 1; ALT levels remained higher at day 2 in group L. LTx from high risk donors (DRI > 2) revealed a trend towards lower transaminases during the first two days after transplantation in group H. One month and 1-year patient survival were similar in groups L and H. High preoperative bilirubin did not affect the risk for early graft dysfunction (EGD), death, or graft loss during the first year after transplantation nor the incidence of acute rejection. LTx using donors with DRI > 2 resulted in similar rates of EGD in both groups. Conclusion. Increased bilirubin appears to reduce the early IRI after LTx yet this improvement was insufficient to improve the clinical outcome.

摘要

背景。外源性胆红素因其抗氧化特性可能减轻实验性缺血再灌注损伤(IRI)。我们研究了受体早期移植肝暴露于高胆红素水平是否会影响肝移植(LTx)后的早期IRI及预后。方法。在427例LTx患者中,基于术后第1天胆红素和天冬氨酸转氨酶(AST)绘制的AUROC曲线确定受体移植前胆红素的临界值为2.04mg/dL。将受体分为低胆红素组(L组,n = 152)和高胆红素组(H组,n = 275)。两组的供体相关变量(年龄、保存时间、供体体重指数>28及供体风险指数(DRI))相似。结果。L组术后第1天丙氨酸转氨酶(ALT)和AST水平较高;L组术后第2天ALT水平仍较高。高风险供体(DRI>2)的LTx显示,H组移植后前两天转氨酶有降低趋势。L组和H组1个月及1年患者生存率相似。术前高胆红素不影响移植后第1年早期移植物功能障碍(EGD)、死亡或移植物丢失风险,也不影响急性排斥反应发生率。使用DRI>2供体的LTx两组EGD发生率相似。结论。胆红素升高似乎可减轻LTx后的早期IRI,但这种改善不足以改善临床结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed30/4893452/dfa4191ebf08/GRP2016-6964856.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed30/4893452/dfa4191ebf08/GRP2016-6964856.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed30/4893452/dfa4191ebf08/GRP2016-6964856.001.jpg

相似文献

1
Recipient Hyperbilirubinemia May Reduce Ischemia-Reperfusion Injury but Fails to Improve Outcome in Clinical Liver Transplantation.受体高胆红素血症可能减轻缺血再灌注损伤,但未能改善临床肝移植的预后。
Gastroenterol Res Pract. 2016;2016:6964856. doi: 10.1155/2016/6964856. Epub 2016 May 22.
2
High preoperative bilirubin values protect against reperfusion injury after live donor liver transplantation.术前高胆红素值可预防活体肝移植后的再灌注损伤。
Transpl Int. 2015 Nov;28(11):1317-25. doi: 10.1111/tri.12634. Epub 2015 Jul 23.
3
Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.利用移植后风险评分模型评估肝移植物早期功能。
JAMA Surg. 2018 May 1;153(5):436-444. doi: 10.1001/jamasurg.2017.5040.
4
The impact of donor liver graft quality on postoperative outcome in liver transplant recipients. A single centre experience.供肝质量对肝移植受者术后结局的影响。单中心经验。
Rom J Anaesth Intensive Care. 2016 Apr;23(1):19-26. doi: 10.21454/rjaic.7518.231.gft.
5
Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation.胸腺球蛋白与肾肝移植中的缺血再灌注损伤
Nephrol Dial Transplant. 2007 Sep;22 Suppl 8:viii54-viii60. doi: 10.1093/ndt/gfm651.
6
Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury.抗胸腺细胞球蛋白诱导可保护肝脏同种异体移植物免受缺血/再灌注损伤。
Clin Transplant. 2005 Aug;19(4):507-11. doi: 10.1111/j.1399-0012.2005.00375.x.
7
[Effects of N-acetylcysteine on apoptosis induced by myocardial ischemia reperfusion injury in rats' heart transplantation].N-乙酰半胱氨酸对大鼠心脏移植心肌缺血再灌注损伤诱导的细胞凋亡的影响
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2013 Oct;27(10):1234-9.
8
Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation.术前血清胆红素升高可改善肝移植术后的再灌注损伤及生存率。
Transplant Direct. 2017 Jul 5;3(8):e187. doi: 10.1097/TXD.0000000000000684. eCollection 2017 Aug.
9
Risk factors, surgical complications and graft survival in liver transplant recipients with early allograft dysfunction.肝移植受者早期移植物功能障碍的风险因素、手术并发症和移植物存活率。
Hepatobiliary Pancreat Dis Int. 2019 Oct;18(5):423-429. doi: 10.1016/j.hbpd.2019.02.005. Epub 2019 Feb 25.
10
A single-center experience with retrograde reperfusion in liver transplantation.肝移植中逆行再灌注的单中心经验
Transpl Int. 2003 Oct;16(10):730-5. doi: 10.1007/s00147-003-0621-3. Epub 2003 Jun 18.

本文引用的文献

1
High preoperative bilirubin values protect against reperfusion injury after live donor liver transplantation.术前高胆红素值可预防活体肝移植后的再灌注损伤。
Transpl Int. 2015 Nov;28(11):1317-25. doi: 10.1111/tri.12634. Epub 2015 Jul 23.
2
Plasma bilirubin and late graft failure in renal transplant recipients.血浆胆红素与肾移植受者的晚期移植物失功。
Transpl Int. 2012 Aug;25(8):876-81. doi: 10.1111/j.1432-2277.2012.01515.x. Epub 2012 Jun 21.
3
Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
质量较低的器官应该给病情最轻的患者吗?终末期肝病评分和供体风险指数作为早期移植肝功能障碍预测指标的模型。
Transplant Proc. 2012 Jun;44(5):1303-6. doi: 10.1016/j.transproceed.2012.01.115.
4
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.验证肝移植受者早期移植物功能障碍的现行定义,并分析其危险因素。
Liver Transpl. 2010 Aug;16(8):943-9. doi: 10.1002/lt.22091.
5
Effective bilirubin reduction by single-pass albumin dialysis in liver failure.单次白蛋白透析在肝衰竭中有效降低胆红素。
Artif Organs. 2009 Aug;33(8):648-53. doi: 10.1111/j.1525-1594.2009.00758.x. Epub 2009 Jun 28.
6
Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt.细胞表面胆绿素还原酶通过磷脂酰肌醇3激酶和Akt介导胆绿素诱导的抗炎作用。
J Biol Chem. 2009 Aug 7;284(32):21369-78. doi: 10.1074/jbc.M109.027433. Epub 2009 Jun 9.
7
Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond.选择肝硬化的最佳预后系统:终末期肝病及其他模型
Liver Int. 2008 May;28(5):606-13. doi: 10.1111/j.1478-3231.2008.01727.x.
8
The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality.已故供体肝移植的生存获益与候选者疾病严重程度及供体质量的关系。
Am J Transplant. 2008 Feb;8(2):419-25. doi: 10.1111/j.1600-6143.2007.02086.x. Epub 2008 Jan 7.
9
Protocols and mechanisms for remote ischemic preconditioning: a novel method for reducing ischemia reperfusion injury.远程缺血预处理的方案与机制:一种减轻缺血再灌注损伤的新方法。
Transplantation. 2007 Aug 27;84(4):445-58. doi: 10.1097/01.tp.0000228235.55419.e8.
10
Bilirubin as an antioxidant in micelles and lipid bilayers: its contribution to the total antioxidant capacity of human blood plasma.胆红素在胶束和脂质双层中作为抗氧化剂:其对人血浆总抗氧化能力的贡献。
Free Radic Biol Med. 2007 Aug 15;43(4):600-9. doi: 10.1016/j.freeradbiomed.2007.05.020. Epub 2007 May 26.